Kinins and their receptors in hyperalgesia

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 6, 1997, Pages 704-712

  Dray, Andy ^a  

^a Astra Research Centre Montreal   (Canada)

Author keywords

Analgesia; Central nervous system; Inflammation; Pain; Sensory nerves

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; CYTOKINE; KALLIDIN; KININ; PROSTANOID;

CONFERENCE PAPER; ETIOLOGY; HUMAN; HYPERALGESIA; NONHUMAN; PRIORITY JOURNAL;

EID: 0030726331     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y97-068     Document Type: Conference Paper

References (104)

1. Andersson, P.B., Perry, V.H., and Gordon, S. 1992. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience, 48: 169-186.
2. Andreeva, L., and Rang, H.P. 1993. Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro. Br. J. Pharmacol. 108: 185-190.
3. Andres, K.H., Von During, M., Muszynski, K., and Schmidt, R.F. 1987. Nerve fibres and their terminals of the dura mater encephali of the rat. Anat. Embryol. 175: 289-301.
4. Babbedge, R., Dray, A., and Urban, L. 1995. Bradykinin depolarizes the rat isolated superior cervical ganglion via B2 receptor activation. Neurosci. Lett. 193: 161-164.
5. Banati, R.B., Gehrmann, J., Schubert, P., and Kreutzberg, G.W. 1993. Cytotoxicity of microglia. Glia, 7: 111-118.
6. Bauer, M.B., Simons, M.L., Murphy, S., and Gebhart, G.F. 1993. Bradykinin and capsaicin stimulate cyclic GMP production in cultured dorsal root ganglion neurons via a nitrosyl intermediate. J. Neurosci. Res. 36: 280-289.
7. Bhoola, K.D., Figueroa, C.D., and Worthy, K. 1992. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44: 1-80.
8. 2-induced activation and sensitization of articular mechanonociceptors. Neurosci. Lett. 124: 5-8.
9. Boivie, J. 1994. Central pain. In Textbook of pain. 3rd ed. Edited by P.D. Wall and R. Melzack. Churchill Livingstone, London. pp. 871-902.
10. Boyce, S., Rupniak, N.M., Carlson, E.J., Webb, J., Borkowski, J.A., Hess, J.F., Strader, C.D., and Hill, R.G. 1996. Nociception and inflammatory hyperalgesia in B2 bradykinin receptor knockout mice. Immunopharmacology, 33: 333-335.
11. Bradley, C., and Burgess, G. 1993. A nitric oxide synthase inhibitor reduces desensitisation of bradykinin-induced activation of phospholipase C in sensory neurones. Trans. Biochem. Soc. 21: 4353.
12. Brain, S.D., and Williams, T.J. 1985. Inflammatory oedema induced by synergism between calcitonin gene related peptide and mediators of increased vascular permeability. Br. J. Pharmacol. 86: 855-860.
13. Bueb, J.L., Mousli, M., Bronner, C., Routot, B., and Landry, Y. 1990. Activation of Gi-like proteins, a receptor independent effect of kinins in mast cells. Mol. Pharmacol. 38: 816-822.
14. Burch, R.M., and DeHaas, C. 1988. A bradykinin antagonist inhibits carageenin oedema in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:189-193.
15. Burch, R.M., and Tiffany, C.W. 1989. Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin, and other agonists. J. Cell. Physiol. 141: 85-89.
16. Burdin, T.A., Graeff, F.G., and Pela, I.R. 1992. Opioid mediation of the antiaversive and hyperalgesic actions of bradykinin injected into the dorsal periaqueductal gray of the rat. Physiol. Behav. 52: 405-410.
17. Burgess, G.M, Mullaney, J., McNeil, M., Dunn, P., and Rang, H.P. 1989a. Second messengers involved in the action of bradykinin on cultured sensory neurones. J. Neurosci. 9: 3314-3325.
18. Burgess, G.M., Mullaney, I., McNeill, M., Coote, P.R., Minhas, A., and Wood, J.N. 1989b. Activation of guanylate cyclase by bradykinin in rat sensory neurones is mediated by calcium influx: possible role of the increase in cyclic GMP. J. Neurochem. 53: 1212-1218.
19. Chapman, V., and Dickenson, A.H. 1992. The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur. J. Pharmacol. 219: 427-433.
20. Chulak, C., Couture, R., and Foucart, S. 1995. Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria. Br. J. Pharmacol. 115:330-334.
21. Clark, W.G. 1979. Kinins and the peripheral and central nervous systems. In Handbook of experimental pharmacology. Vol. XXV (Suppl.). Edited by E.G. Erdos. Springer-Verlag, New York. pp. 312-356.
22. Correa, F.M., Innis, R.B., Uhl, G.R., and Snyder, S.H. 1979. Bradykinin-like immunoreactive neuronal systems localized histochemically in rat brain. Proc. Natl. Acad. Sci. U.S.A. 76: 1489-1493.
23. Couto, L.B., Correa, F.M.A., and Pela, I.R. 1995. Bradykinin microinjection into the locus coeruleus induces antinociception in rats. Abstr. B20. In Kinins '95. Edited by J. Stewart, J.C. Cheronis, and E.T. Whalley. Unpublished.
24. Cruwys, S.C., Garrett, N.E., Perkins, M.N., Blake, D.R., and Kidd, B.L. 1994. The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br. J. Pharamcol. 113: 940-944.
25. 2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br. J. Pharmacol. 113: 63-68.
26. Davis, K.D., and Dostrovsky, J.O. 1988. Cerebrovascular application of bradykinin excites central sensory neurons. Brain Res. 446: 401-406.
27. 9 BK in carrageenen-induced edema. Peptides. 17: 1009-1015.
28. Dray, A. 1994. Tasting the inflammatory soup: role of peripheral neurones. Pain Rev. 1: 153-171.
29. Dray, A. 1995. Inflammatory mediators of pain. Br. J. Anaesth. 75: 125-131.
30. Dray, A., and Perkins, M. 1993. Bradykinin and inflammatory pain. Trends Neurosci. 16: 99-104.
31. Dray, A., and Urban, L. 1996. New pharmacological strategies for pain relief. Annu. Rev. Pharmacol. Toxicol. 36: 253-280.
32. Dray, A., Patel, I.A., Perkins, M.N., and Rueff, A. 1992. Bradykinin-induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord-tail preparation in vitro. Br. J. Pharmacol. 107: 1129-1134.
33. Dunn, P.M., and Rang, H. P. 1990. Bradykinin-induced depolarization of primary afferent nerve terminals in the neonatal rat spinal cord in vitro. Br. J. Pharmacol. 100: 656-660.
34. 2+ currents by neuropeptide Y. J. Neurosci. 8: 2447-2451.
35. Ferreira, S.H., Lorenzetti, B.B., and Poole, S. 1993. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 110: 1227-1231.
36. 3H)bradykinin binding sites in guinea-pig central nervous system: possible existence of B2 subtypes. Life Sci. 44: 1645-1653.
37. Gammon, C.M, Allen, A.C., and Morell, P. 1989. Bradykinin stimulates phosphoinositide hydrolysis and mobilisation of arachidonic acid in dorsal root ganglion neurons. J. Neurochem. 53: 95-101.
38. 9-bradykinin in experimental allergic encephalomyclitis. J. Neurol. Sci. 83: 211-217.
39. + current in nociceptors. Proc. Natl. Acad. Sci. U.S.A. 93: 1108-1112.
40. Hall, J.M. 1992. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56: 131-190.
41. Heapy, C.G., Shaw, J.S., and Farmer, S.C. 1993. Differential sensitivity of antinociceptive assays to the bradykinin antagonist Hoe 140. Br. J. Pharmacol. 108: 209-213.
42. Hess, J.F., Borkowski, J.A., Young, G.S., Strader, C.D., and Ransom, R.W. 1992. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184: 260-268.
43. Holthusen, H., and Arndt, J.O. 1994. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci. Lett. 165: 71-74.
44. Hosli, E., and Hosli, L. 1993. Receptors for neurotransmitters on astrocytes in the mammalian central nervous system. Prog. Neurobiol. (Oxf), 40: 477-506.
45. Jacques, L., and Couture, R. 1990. Studies on the vascular permeability induced by intrathecal substance P and bradykinin in the rat. Eur. J. Pharmacol. 184: 9-20.
46. Janig, W., and Kolzenburg, M. 1991. Receptive properties of pial afferents. Pain, 45: 77-85.
47. Jeftinija, S. 1994. Bradykinin excites tetrodotoxin-resistant primary afferent fibres. Brain Res. 665: 69-76.
48. Jones, S., Brown, D.A., Milligan, G., Wilier, E., Buckley, N.J., and Caulfield, M.P. 1995. Bradykinin excites rat sympathetic neurons by inhibition of M current through a mechanism involving B2 receptors and G alpha q/11. Neuron, 14: 399-405.
49. Kay, A.B., and Kaplan, A.P. 1975. Chemotaxis and haemostasis. Br. J. Haematol. 31: 417-422.
50. Khasar, S.G., Miao, F.J.-P., and Levine, J.D. 1995. Inflammation modulates the contribution of receptor-subtypes to bradykinin-induced hyperalgesia. Neuroscience, 69: 685-690.
51. Kolzenburg, M., Kress, M., and Reeh, P.W. 1992. The nociceptor sensitiation by bradykinin does not depend on sympathetic neurons. Neuroscience, 46: 465-473.
52. Kurosawa, M., Messlinger, K., Pawlak, M., and Schmidt, R.F. 1995. Increases of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin-gene related peptide. Br. J. Pharamacol. 114: 1397-1402.
53. Laneuville, O., and Couture, R. 1987. Bradykinin analogue blocks bradykinin-induced inhibition of a spinal nociceptive reflex in the rat. Eur. J. Pharmacol. 137: 281-285.
54. Laneuville, O., Reader, T.A., and Couture, R. 1989. Intrathecal bradykinin acts presynaptically on spinal noradrenergic terminals to produce antinociception in the rat. Eur. J. Pharmacol. 159: 273-283.
55. Levine, J.D., Fields, H.L., and Basbaum, A.I. 1993. Peptides and the primary afferent nociceptor. J. Neurosci. 13: 2273-2286.
56. 8]-bradykinin receptor binding sites in the rat spinal cord: effects of neonatal capsaicin, noradrenergic deafferentation, dorsal rhizotomy and peripheral axotomy. Neuroscience, 68: 867-881.
57. MacNeil, T., Bierilo, K.K., Menke, J.G., and Hess, J.F. 1995. Cloning and pharmacological characterization of a rabbit bradykinin B1 receptor. Biochem. Biophys. Acta, 1264: 223-228.
58. Malmberg, A.B., and Yaksh, T.L. 1992. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 263: 136-146.
59. Marceau, F. 1995. Kinin B1 receptors: a review. Immunology, 30: 1-26.
60. Markowitz, S., Saito, K., and Moskowitz, M.A. 1987. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci. 7: 4129-4136.
61. 2 bradykinin receptor. Proc. Natl. Acad. Sci. U.S.A. 88: 7724-7728.
62. McGehee, D.S., Goy, M.F., and Oxford, G.S. 1992. Involvement of the nitric oxide - cyclic GMP pathway in the desensitization of bradykinin responses of cultured rat sensory neurons. Neuron, 9: 315-324.
63. Meiler, S.T., and Gebhart, G.F. 1992. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neuroscience, 48: 501-524.
64. Menke, J.G., Borkowski, J.A., Bierilo, K., MacNeil, T., Derrick, A.W., Schneck, K.A., Ransom, R.W., Strader, K.D., Linemeyer, D.L., and Hess, J.F. 1994. Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem. 269: 21 583-21 586.
65. Mense, S. 1993. Nociception from skeletal muscle in relation to clinical muscle pain. Pain, 54: 241-289.
66. Meyer, R.A., Davis, K.D., Raja, S.N., and Campbell, J.N. 1992. Sympathectomy does not abolish bradykinin-induced cutaneous hyperalgesia in man. Pain, 51: 323-327.
67. Moskowitz, M.A., Brody, M., and Liu-Chen, L.Y. 1983. In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience, 9: 809-814.
68. Murone, C., Chai, S.Y., and Mendelsohn, F.A.O. 1995. Bradykinin B2 receptor localization in sheep brain. Abstr. B19. In Kinins '95. Edited by J. Stewart, J.C. Cheronis, and E. Whalley.
69. Nagy, I., Pabla, R., Matesz, C., Dray, A., Woolf, C.J., and Urban, L. 1993. Cobalt uptake enables identification of capsaicin and bradykinin sensitive sub-populations of rat dorsal root ganglion cells in vitro. Neuroscience, 56: 167-172.
70. 2 of bradykinin activation of embryonic rat sensory neurones. J. Physiol. (London), 480: 485-492.
71. Nicol, G.D., Klingberg, D.K., and Vasko, M.R. 1992. Prostaglandin E2 incresaes calcium conductance and stimulates release of substance P in avian sensory neurons. J. Neurosci. 12: 1917-1927.
72. Olesen, J., Thomsen, L.L., and Iversen, H. 1994. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol. Sci. 15: 149-153.
73. Parpura, V., Basarsky, T.A., Liu, F., Jeftinija, K., Jeftinija, S., and Haydon, P.G. 1994. Glutamate mediated astrocyte-neuron signalling. Nature (London), 369: 744-747.
74. Parpura, V., Liu, F., Jeftinija, K.V., Haydon, P.G., and Jeftinija, S.D. 1995. Neuroligand-evoked calcium dependent release of excitatory amino acids from Schwann cells. J. Neurosci. 15: 5831-5839.
75. Perkins, M.N., and Kelly, D. 1993. Induction of bradykinin B1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol. 110: 1441-1444.
76. 8] Bk and HOE 140 in two models of persistent hyperalgesia in the rat. Pain, 53: 191-197.
77. Perry, V.H., Andersson, P.-B., and Gordon, S. 1993. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16: 268-273.
78. Poole, S., Cunha, F.Q., Selkirk, S., Lorenzetti, B.B., and Ferreira, S.H. 1995. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br. J. Pharmacol. 115: 684-688.
79. 125I) bradykinin binding sites in guinea pig brain. Brain Res. 577: 73-79.
80. Rang, H.P., Bevan, S.J., and Dray, A. 1994. Nociceptive peripheral neurones: cellular properties. In Textbook of pain. Edited by P.D. Wall and R. Melzack. Churchill Livingstone, London. pp. 57-78.
81. Rao, P.J., and Bhattacharya, S.K. 1988. Hyperthermic effect of centrally administered bradykinin in the rat: role of prostaglandins and serotonin. Int. J. Hyperthermia, 4: 183-189.
82. Ribeiro, S.A., and Rocha e Silva, M. 1973. Antinociceptive action of bradykinin and related kinins of larger molecular weights by the intraventricular route. Br. J. Pharmacol. 47: 517-528.
83. Roscher, A.A., Manganiello, V., Jesselma, C.L., and Moss, J. 1994. Autoregulation of bradykinin receptors and bardykinin-induced prostacyclin formation in human fibroblasts. J. Clin. Invest. 74: 552-558.
84. Rueff, A., and Dray, A. 1993. Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins. Neuroscience, 54: 527-535.
85. Rueff, A., Patel, I.A., Urban, L., and Dray, A. 1994. Regulation of bradykinin sensitivity in peripheral sensory fibres of the neonatal rat by nitric oxide and cyclic GMP. Neuropharmacology, 33: 1139-1145.
86. Sarker, M.H., and Fraser, P.A. 1994. Evidence that bradykinin increases permeability of single cerebral microvessels via free radicals. J. Physiol. (London), 479: 36P.
87. Schaible, H.-G., and Grubb, B.D. 1993. Afferent and spinal mechanisms of joint pain. Pain, 55: 5-54.
88. 2. J. Physiol. (London), 403: 91-104.
89. Schepelmann, K., Messlinger, K., and Schmidt, R.F. 1993. The effect of phorbol ester on slowly conducting afferents of the cat's knee joint. Exp. Brain Res. 92: 391-398.
90. Schuligoi, R., Donnerer, J., and Amann, R. 1994. Bradykinin-induced sensitization of afferent neurons in the rat paw. Neuroscience, 59: 211-215.
91. Seabrook, G.R., Bowery, B.J., and Hill, R.G. 1995. Bradykinin receptors in mouse and rat isolated superior cervical ganglion. Br. J. Pharmacol. 115: 368-372.
92. Sicuteri, F. 1970. Bradykinin and intracranial circulation in man. Handb. Exp. Pharmacol. 25: 482-515.
93. Snyder, S.H. 1980. Brain peptides as neurotransmitters. Science (Washington, D.C.), 209: 976-983.
94. Stephens, G.J., Marriott, D.R., Djamgoz, M.B.A., and Wilkin, G.P. 1993. Electrophysiological and biochemical evidence for bradykinin receptors on cultured rat cortical oligodendrocytes. Neurosci. Lett. 153: 223-226.
95. Steranka, L.R., Manning, D.C., DeHaas, C.J., Ferkany, J.W., Borosky, S.A., Connor, J.R., Vavrek, R.J., Stewart, J.M., and Snyder, S.H. 1988. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc. Natl. Acad. Sci. U.S.A. 85: 3245-3249.
96. Taiwo, Y., and Levine, J.D. 1988. Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia. Brain Res. 458: 402-406.
97. Tiffany, C.W., and Burch, R.M. 1989. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett. 247: 189-192.
98. Undem, B.J., and Weinreich, D. 1993. Electrophysiological properties and chemosensitivity of guinea pig nodose ganglion neurons in vitro. J. Auton. Nerv. Syst. 44: 17-34.
99. Unterberg, A., Wahl, M., and Baethmann, A. 1984. Effects of bradykinin on permeability and diameter of pial vessels in vivo. J. Cereb. Blood Flow Metab. 4: 574-585.
100. Vandekerchkove, F., Opdenakker, G., Van Ranst, M., Lenaerts, J.-P., Put, W., Billiau, A., and Van Damme, J. 1991. Bradykinin induces interleukin-6 and synergizes with interleukin-1. Lymphokine Cytokine Res. 10: 285-289.
101. Walker, K., Perkins, M.N., and Dray, A. 1995. Kinins and kinin receptors in the nervous system. Neurochem. Int. 26: 1-16.
102. Walker, K., Dray, A., and Perkins, M. 1996a. Hyperalgesia in rats following intracerebroventricular administration of endotoxin: effects of bradykinin B1 and B2 receptor antagonist treatment. Pain, 65: 211-219.
103. Walker, K., Dray, A., and Perkins, M. 1996b. Development of hyperthermia following intracerebroventricular administration of endotoxin in the rat: effects of kinin B1 and B2 receptor antagonists. Br. J. Pharmacol. 117: 684-688.
104. Yirmiya, R., Rosen, H., Donchin, O., and Ovadia, H. 1994. Behavioral effects of lipopolysaccharide in rats: involvement of endogenous opioids. Brain Res. 648: 80-86.